Dr. Tackett will introduce the relatively new NIGMS R24 National Resource for Quantitative Proteomics. The fundamental mission of this National Resource is to provide NIH-funded investigators unmatched access to state-of-the-art quantitative proteomics platforms and skilled bioinformaticians to increase cutting-edge research. During the presentation, I will provide examples of how we have enabled research relevant to the field of Cancer Immunology.

Dr. Huang is one of the nation's leading experts in the study of effective vaccines against tumor associated carbohydrate antigens (TACAs) for cancer treatment and prevention. He will present strategies in engineering virus-like particle bacteriophage Qβ to enhance the immunogenicity of TACAs as potential anti-cancer vaccines using ganglioside GD2 as a representative antigen, which are overexpressed on many tumor types, utilizing N-acetamide (NHAc) to enhance immunogenicity.